ADCAN Pharma, a leading UAE-based pharmaceutical manufacturer and the nation’s first producer of oncology and hormone products, has signed a strategic partnership agreement with Galenicum, a leading Spanish pharmaceutical company, to strengthen the UAE’s pharmaceutical manufacturing and regulatory capabilities.
The 7th Annual Emirates Oncology Society Conference has recommended expanding the use of artificial intelligence to predict cancer treatment outcomes, advancing the use of immunotherapy in patients with advanced-stage cancer.
